ATP Synthase 6

Alternative Names

  • MTATP6
  • Complex V, ATP Synthase, Subunit ATPase 6
  • ATP6
  • Mitochondrial Complex V (ATP Synthase) Deficiency, Mitochondrial Type 1
  • MC5DM1
  • Ataxia and Polyneuropathy, Adult-Onset
  • Cardiomyopathy, Infantile Hypertrophic

Associated Diseases

Leber Optic Atrophy

Description

Mitochondria have their own DNA (mtDNA, which is a 16.5-kb circular double-stranded DNA (dsDNA), encoding 13 polypeptides, 22 transfer RNA (tRNA), and two ribosomal RNA (rRNA).  The 13 polypeptides are subunits of a series of large enzyme complexes located in the inner mitochondrial membrane necessary for ATP production via oxidative phosphorylation.  The protein encoded by the MT-ATP6 gene belongs to the mitochondrial respiratory chain complex.  The MT-ATP6 protein is one subunit of a large enzyme called ATP synthase, also known as complex V.  This enzyme produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain.  F-type ATPases have two components, CF(1) - the catalytic core - and CF(0) - the membrane proton channel, linked together by a central stalk and a peripheral stalk.  CF(1) has five subunits: alpha(3), beta(3), gamma(1), delta(1), and epsilon(1).  Complex V is responsible for the final step of oxidative phosphorylation, it allows protons to flow across CF(0) segment inside mitochondria, and then the CF(1) segment uses the energy created by this proton flow to convert a molecule called adenosine diphosphate (ADP) to ATP.

Molecular Genetics

The MT-ATP6 gene has one coding exon, and it is located in the mitochondrial DNA between bases 8,526 and 9,206.  Mutations in the MT-ATP6 gene have been associated with many diseases including Leigh syndrome, familial bilateral striatal necrosis, and neuropathy, ataxia, and retinitis pigmentosa (NARP).  About 10-20% of Leigh syndrome cases are caused by mutations in this gene.  The most common genetic change associated with NARP and Leigh syndrome is T8993G.

Epidemiology in the Arab World

View Map

Other Reports

Saudi Arabia

In order to determine the role of mitochondrial DNA mutations in thyroid tumorigenesis, Abu-Amero et al. (2005) sequenced the entire mtDNA from 24 thyroid tumor specimens and four thyroid cancer cell lines.  Somatic mutations were identified in 37% of primary thyroid carcinomas (PTC) and among 25% of multinodular hyperplasia cases.  Most mutations were nucleotide substitutions resulting in missense mutations.  Of these mutations, 14 were nonsynonymous and 36 were synonymous.  One novel synonymous mtDNA sequence change was detected in the ATPase 6 gene in both PTC and control samples.  In a later study, Abu-Amero et al. (2006) sequenced the entire coding region of mitochondrial DNA for 26 MTC patients and 119 normal population controls.  Of the MTC patients, 13 were sporadic, nine had MEN 2A, one had MEN 2B, and three had FMTC.  In 20 MTC samples, 41 nonsynonymous mutations were detected; nine were from sporadic MTC and 11 were from familial MTC and MEN2.  Also, 15 synonymous mtDNA sequence variants were found in MTC samples, seven of them were novel.  Twenty seven mutations were transversions; 22 nonsynonymous and six synonymous.  These transversion variants were only detected in FMTC/MEN2 while transition variants were mainly found in sporadic MTC cases.  Eight sequence changes were identified in the MT-ATP6 gene, six of them were nonsynonymous.  None of these mutations were present in the normal controls, suggesting that mtDNA mutations may be involved in MTC tumorigenesis and progression.  Abu-Amero and Bosley (2006) studied further the molecular and biological characteristics of mitochondria in patients with Leber hereditary optic neuropathy (LHON)-like optic neuropathies.  Thirty five patients (21 males and 14 females) and 159 matched controls from Saudi Arabia were included in this study.  Forty one non-synonymous mtDNA sequence variants were identified in LHON patients; 14 were pathogenic.  Of these variants, 21 were in complex I, seven in complex III, five in complex IV, six in complex V, one in tRNA glutamine, and one in 12S rRNA.  Similar to previous reports on mutation association with LHON, these mtDNA changes were transitions.  Six variants were found within the MT-ATP6 gene: A8656T, A8701G, A8836G, A8860G, G9053A, and G9055A.  Of these variants, the A8836G mutation was pathogenic.

© CAGS 2024. All rights reserved.